Lonza

lonza.com

Lonza Milano, S.r.l.

Via Galileo Galilei
24043 Caravaggio
Italy

Phone

lonza.com
Contact
Profile News

About Lonza

Read more about Lonza

Advertisement

Efficient inline analysis for liquids and solids
Efficient inline analysis for liquids and solids
Revolutionize your production: real-time Raman analysis for maximum efficiency
Revolutionize your production: real-time Raman analysis for maximum efficiency
Freeze Drying with the Refrigerant of the Future
Freeze Drying with the Refrigerant of the Future

News about Lonza

Lonza

04-Nov-2025 | business & finance

Lonza to expand bioscience testing offering with the acquisition of Redberry

Technology speeds up sterility testing from 14 to just 4 days

Read news
Lonza

30-Jan-2025 | business & finance

Lonza Delivers Solid 2024 Performance with CER Sales in Line with Prior Year and 29.0% CORE EBITDA Margin

"Looking ahead to 2025 and beyond, we are focusing on implementing our One Lonza strategy..."

Read news
Lonza

12-Nov-2024 | manufacturing

Lonza expands bioconjugation in Visp with two additional manufacturing suites

Lonza announced it will invest in additional bioconjugation capabilities in Visp (CH). The expansion will add two multipurpose 1,200L manufacturing suites ...

Read news
Lonza

02-Jul-2024 | people

Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand

Albert M. Baehny will retire from Lonza Group following a transition period

Read news
Lonza

08-May-2024 | manufacturing

Fast, robust series production of nanoparticles

Next-generation encapsulation technology

Read news
Lonza

02-Apr-2024 | people

Lonza Appoints Wolfgang Wienand as New CEO

Albert M. Baehny will retire from Lonza following a transition period

Read news
Lonza

29-Jan-2024 | people

Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza

Longstanding Chairman of Lonza, Albert Baehny will not stand for re-election

Read news
Lonza

01-Jun-2023 | business & finance

Lonza to Acquire Synaffix

Strengthen Antibody-Drug Conjugates Offering

Read news
Show more news about Lonza

Here you will find Lonza Milano, S.r.l.

Last viewed contents

Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis - Investment led by Boehringer Ingelheim Venture Fund, with the participation of new and existing investors, including Apollo Health Ventures, NRW.Venture, and HTGF

Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis - Investment led by Boehringer Ingelheim Venture Fund, with the participation of new and existing investors, including Apollo Health Ventures, NRW.Venture, and HTGF

Go to page